Wells Fargo & Company Novo Nordisk A S Transaction History

Wells Fargo & Company

$433 Billion
Q4 2024

A detailed history of Wells Fargo & Company transactions in Novo Nordisk A S stock. As of the latest transaction made, Wells Fargo & Company holds 3,673,115 shares of NVO stock, worth $213 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

3,673,115

Previous 4,068,854 9.73%

Holding current value

$213 Million

Previous $484 Million 34.78%

% of portfolio

0.07%

Previous 0.11%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	SELL	$85.0 - $120.04 $33.6 Million - $47.5 Million	-395,739 Reduced 9.73%	3,673,115 $316 Million
Q3 2024 Nov 13, 2024	SELL	$119.07 - $145.42 $2.11 Million - $2.57 Million	-17,702 Reduced 0.43%	4,068,854 $484 Million
Q2 2024 Aug 13, 2024	BUY	$122.71 - $146.91 $16.3 Million - $19.5 Million	132,556 Added 3.35%	4,086,556 $583 Million
Q1 2024 May 10, 2024	BUY	$102.11 - $135.92 $15.8 Million - $21 Million	154,751 Added 4.07%	3,954,000 $508 Million
Q4 2023 Feb 09, 2024	BUY	$87.78 - $105.45 $10.8 Million - $12.9 Million	122,484 Added 3.33%	3,799,249 $393 Million
Q3 2023 Nov 13, 2023	BUY	$90.94 - $199.54 $182 Million - $400 Million	2,006,189 Added 120.09%	3,676,765 $334 Million
Q2 2023 Aug 15, 2023	BUY	$155.98 - $172.65 $12.7 Million - $14.1 Million	81,545 Added 5.13%	1,670,576 $270 Million
Q1 2023 May 12, 2023	SELL	$132.34 - $159.14 $1.59 Million - $1.91 Million	-12,027 Reduced 0.75%	1,589,031 $253 Million
Q4 2022 Feb 13, 2023	SELL	$102.55 - $135.33 $243,146 - $320,867	-2,371 Reduced 0.15%	1,601,058 $217 Million
Q3 2022 Nov 14, 2022	SELL	$95.28 - $116.93 $17.5 Million - $21.5 Million	-183,887 Reduced 10.29%	1,603,429 $160 Million
Q2 2022 Aug 12, 2022	BUY	$103.24 - $121.81 $9.38 Million - $11.1 Million	90,857 Added 5.36%	1,787,316 $199 Million
Q1 2022 May 16, 2022	BUY	$93.1 - $112.54 $16.4 Million - $19.9 Million	176,527 Added 11.61%	1,696,459 $188 Million
Q4 2021 Feb 14, 2022	SELL	$95.88 - $117.08 $1.67 Million - $2.04 Million	-17,385 Reduced 1.13%	1,519,932 $170 Million
Q3 2021 Nov 15, 2021	BUY	$84.42 - $106.62 $985,772 - $1.25 Million	11,677 Added 0.77%	1,537,317 $148 Million
Q2 2021 Aug 16, 2021	SELL	$67.66 - $84.76 $15.7 Million - $19.7 Million	-232,206 Reduced 13.21%	1,525,640 $128 Million
Q1 2021 May 13, 2021	BUY	$67.06 - $75.82 $6.13 Million - $6.93 Million	91,455 Added 5.49%	1,757,846 $119 Million
Q4 2020 Feb 09, 2021	BUY	$63.89 - $73.8 $3.79 Million - $4.38 Million	59,286 Added 3.69%	1,666,391 $116 Million
Q3 2020 Nov 05, 2020	BUY	$63.69 - $70.22 $11 Million - $12.2 Million	173,193 Added 12.08%	1,607,105 $112 Million
Q2 2020 Aug 13, 2020	SELL	$58.54 - $67.94 $543,134 - $630,347	-9,278 Reduced 0.64%	1,433,912 $93.9 Million
Q1 2020 May 14, 2020	BUY	$49.46 - $64.78 $71.4 Million - $93.5 Million	1,443,190 New	1,443,190 $86.9 Million

Others Institutions Holding NVO

# of Institutions

1,869

Shares Held

336M

Call Options Held

11.9M

Put Options Held

10.6M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $131B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Novo Nordisk A S Transaction History